Decrease in plasma cholesteryl-ester transfer protein activity with simvastatin treatment in patients with type IIa hypercholesterolemia

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 1, 1996, Pages 42-47

  Hibino, Takeshi ^a   Sakuma, Nagahiko ^a   Sato, Takaaki ^a   Yoneyama, Akihiko ^a   Fujinami, Takao ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 2; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030020043     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80028-2     Document Type: Article

References (21)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
2. Castelli WP, Garrison RJ, Wilson PWF, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA. 1986;256:2835-2838.
3. Fujinami T, Hirata H, Hayano J, et al. Coronary risk factors in angiographically defined patients with chest pain. Jpn J Med. 1990;29:462-468.
4. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA. 1984;251:351-374.
5. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors and incidence of coronary heart disease. NEJM. 1987;317:1237-1245.
6. Todd PA, Goa KL. Simvastatin: A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs. 1990;40:583-607.
7. Illingworth DR, Erkelens DW, Keller U, et al. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet. 1994;343:1554-1555.
8. Glomset JA. The plasma lecithin:cholesterol acyl transferase reaction. J Lipid Res. 1968; 9:155-167.
9. Takata K, Horiuchi S, Rahim ATMA, Morino Y. Receptor-mediated internalization of high density lipoprotein by rat sinusoidal liver cells: Identification of a nonlysosomal endocytic pathway by fluorescence-labeled ligand. J Lipid Res. 1988;29:1117-1126.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
11. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis. 1984;4:49-58.
12. Nagasaki T, Akanuma Y. A new colorimetric method for the determination of plasma lecithin-cholesterol acyltransferase activity. Clin Chim Acta. 1977;75:371-375.
13. McPherson R, Mann CJ, Tall AR, et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Arterioscler Thromb. 1991;11:797-804.
14. Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest. 1991;87:1559-1566.
15. Johansson J, Molgaard J, Olsson AG. Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia. Atherosclerosis. 1991;91:175-184.
16. Weisweiler P. Simvastatin and bezafibrate: Effects on serum lipoproteins and lecithin: Cholesterol acyltransferase activity in familial hypercholesterolaemia. Eur J Clin Pharmacol. 1988;35:579-583.
17. Ahnadi CE, Berthezene F, Ponsin G. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects. Atherosclerosis. 1993;99:219-228.
18. Jiang XC, Magoulas LM, Mar J, et al. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. J Biol Chem. 1993;268:27406-27412.
19. Ma PTS, Gil G, Sudhof TC, et al. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA. 1986;83:8370-8374.
20. Tollefson JH, Liu A, Albers JJ. Regulation of plasma lipid transfer by high-density lipoproteins. Am J Physiol Endocrinol Metab. 1988;255:E894-E902.
21. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.